Target intelligence / Profile preview

Extracellular protein disulfide bonds

Molecular classification
Other (chemical covalent motif in proteins), Found in enzymes (such as protein disulfide isomerase), receptors (such as integrins), and secreted proteins
01

Overview

Extracellular protein disulfide bonds are covalent bridges formed between pairs of cysteine residues within or between polypeptide chains, predominantly in proteins secreted or located at the cell surface. These bonds stabilize protein structure, protect against extracellular proteolysis and oxidation, and enable dynamic regulation of protein conformation and function in response to changes in redox milieu. Enzymes like protein disulfide isomerase (PDI) catalyze their formation and rearrangement, processes which are essential to proper protein folding, activity modulation (e.g., integrin activation, viral entry), and cellular response to oxidative stress. Dysregulation of disulfide bond formation or cleavage is implicated in cancers, neurodegenerative diseases, thrombosis, and infections such as HIV. However, "extracellular protein disulfide bonds" describes a structural motif, not a druggable target, and should be contextualized within the specific proteins containing these bonds[1][2][4][5][6][7].

Other names
Disulfide bridgesS-S bondsProtein disulfide bonds
02

Mechanism of action

Inhibition of thiol isomerases (e.g., PDI) modifies extracellular disulfide exchange and alters cell surface protein functions. Redox modulation for functional regulation of target proteins.

03

Biological functions

Structural stability of extracellular proteinsOxidative folding during protein synthesisRegulation of protein function through redox-sensitive mechanismsProtection against oxidative stressModulation of ligand binding and signal transduction
04

Disease associations

Cancer (dysregulated disulfide formation linked to various cancers)Neurodegenerative disease (such as ALS, Creutzfeldt-Jakob disease)Infection (essential for viral entry, e.g. HIV)Cardiovascular disease (thrombosis)Other (can impact protein misfolding diseases)
05

Safety considerations

Safety concerns are associated with manipulation of disulfide bonds in specific proteins or therapeutic antibodies, not with the motif itself
06

Interacting drugs

Drugs like redox-modulating agents and isomerase inhibitors may influence the formation or cleavage of disulfide bonds indirectly, but there are no drugs that target "extracellular protein disulfide bonds" as a distinct entity

1 more in the full profile.

Beyond the preview

Go deeper on Extracellular protein disulfide bonds.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Extracellular protein disulfide bonds.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call